Kawasaki disease and vasculitis associated with immunization.

作者: Arthur Chang , Shamim Islam

DOI: 10.1111/PED.13590

关键词:

摘要: The etiology and pathogenesis of Kawasaki disease (KD) remain poorly understood. Among the diverse infectious environmental factors examined to be triggers for, or associated with, KD, are immunizations. In this report, we first describe case a Caucasian girl who presented with classic KD shortly after receiving her routine 4 months vaccination series. Prior published reports large epidemiological studies, which explore potential associations between immunization other vasculitides, then comprehensively reviewed. methodologic challenges that complicate analysis in area also considered.

参考文章(18)
Hubert Buyse, Carlota Vinals, Naveen Karkada, Htay Htay Han, The human rotavirus vaccine Rotarix™ in infants: an integrated analysis of safety and reactogenicity. Human Vaccines & Immunotherapeutics. ,vol. 10, pp. 19- 24 ,(2014) , 10.4161/HV.26476
Caterina Bonetto, Francesco Trotta, Patrizia Felicetti, Graciela S Alarcón, Carmela Santuccio, Novilia Sjafri Bachtiar, Yolanda Brauchli Pernus, Rebecca Chandler, Giampiero Girolomoni, Robert DM Hadden, Merita Kucuku, Seza Ozen, Barbara Pahud, Karina Top, Frederick Varricchio, Robert P Wise, Giovanna Zanoni, Saša Živković, Jan Bonhoeffer, Brighton Collaboration Vasculitis Working Group, Vasculitis as an adverse event following immunization – Systematic literature review Vaccine. ,vol. 34, pp. 6641- 6651 ,(2016) , 10.1016/J.VACCINE.2015.09.026
Paul E. M. Fine, Robert T. Chen, Confounding in Studies of Adverse Reactions to Vaccines American Journal of Epidemiology. ,vol. 136, pp. 121- 135 ,(1992) , 10.1093/OXFORDJOURNALS.AJE.A116479
Hung Fu Tseng, Lina S. Sy, In-Lu Amy Liu, Lei Qian, S. Michael Marcy, Eric Weintraub, Katherine Yih, Roger Baxter, Jason M. Glanz, James Donahue, Allison Naleway, James Nordin, Steven J. Jacobsen, Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine. ,vol. 31, pp. 2578- 2583 ,(2013) , 10.1016/J.VACCINE.2013.03.040
Joseph Y. Abrams, Eric S. Weintraub, James M. Baggs, Natalie L. McCarthy, Lawrence B. Schonberger, Grace M. Lee, Nicola P. Klein, Edward A. Belongia, Michael L. Jackson, Allison L. Naleway, James D. Nordin, Simon J. Hambidge, Ermias D. Belay, Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006. Vaccine. ,vol. 33, pp. 382- 387 ,(2015) , 10.1016/J.VACCINE.2014.10.044
Ulrike Uhlig, Karel Kostev, Volker Schuster, Sibylle Koletzko, Holm H. Uhlig, Impact of Rotavirus Vaccination in Germany The Pediatric Infectious Disease Journal. ,vol. 33, pp. e299- e304 ,(2014) , 10.1097/INF.0000000000000441
Wei Hua, Hector S. Izurieta, Barbara Slade, Ermias D. Belay, Penina Haber, Rosemary Tiernan, Emily Jane Woo, John Iskander, M Miles Braun, Robert Ball, Kawasaki Disease After Vaccination: Reports to the Vaccine Adverse Event Reporting System 1990–2007 Pediatric Infectious Disease Journal. ,vol. 28, pp. 943- 947 ,(2009) , 10.1097/INF.0B013E3181A66471
Deonilson Schmöeller, Mauro W. Keiserman, Henrique Luiz Staub, Flávio Petersen Velho, Marily de Fátima Grohe, Yellow fever vaccination and Kawasaki disease. Pediatric Infectious Disease Journal. ,vol. 28, pp. 1037- 1038 ,(2009) , 10.1097/INF.0B013E3181BBC571
Yu-Lung Lau, E Anthony S Nelson, Kin-Hung Poon, Paul KS Chan, Susan Chiu, Rita Sung, Chi Wai Leung, Daniel Ng, Yee Man Ma, Desmond Chan, Tsz Leung Lee, Joyce Tang, Yat Wah Kwan, Patricia Ip, Marco Ho, Lai-Wah Eva Fung, Haiwen Tang, PV Suryakiran, Htay Htay Han, Hans Bock, Hong Kong Rotarix Study Group, Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: a randomized, controlled trial. Vaccine. ,vol. 31, pp. 2253- 2259 ,(2013) , 10.1016/J.VACCINE.2013.03.001
Maria Paulke-Korinek, Herwig Kollaritsch, Stephan W. Aberle, Ines Zwazl, Birgit Schmidle-Loss, Andreas Vécsei, Michael Kundi, Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine. ,vol. 31, pp. 2686- 2691 ,(2013) , 10.1016/J.VACCINE.2013.04.001